Evalve, Inc.: MitraClip(R) Therapy Introduced in Austria

MENLO PARK, Calif., Sept. 9 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, today announced treatment of the first group of patients with the MitraClip((R)) system at the Elisabethinen Krankenhaus, Linz, Austria. The MitraClip((R)) system is the only medical device commercially available in the European Union which provides a non-surgical mitral valve repair option for patients suffering from the effects of functional and degenerative mitral regurgitation (MR).